BENECALORIE Trademark
Trademark Overview
On Monday, March 25, 2002, a trademark application was filed for BENECALORIE with the United States Patent and Trademark Office. The USPTO has given the BENECALORIE trademark a serial number of 78117334. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 17, 2003. This trademark is owned by Novartis AG. The BENECALORIE trademark is filed in the Pharmaceutical Products category with the following description:
Nutritional supplements
General Information
Serial Number | 78117334 |
Word Mark | BENECALORIE |
Filing Date | Monday, March 25, 2002 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, March 17, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Nutritional supplements |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, April 3, 2002 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Novartis AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Basel CH-4056 CH |
Trademark Events
Event Date | Event Description |
Monday, March 17, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, January 2, 2003 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, July 15, 2002 | NON-FINAL ACTION E-MAILED |
Monday, July 15, 2002 | ASSIGNED TO EXAMINER |